| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.007 |